Previous Article | Next Article ![]()
J. Virol., Dec 1995, 7639-7647, Vol 69, No. 12
JM Routes and S Ryan
The reasons for the dissimilar oncogenicities of human adenoviruses and
human papillomaviruses (HPV) in humans are unknown but may relate to
differences in the capacities of the E1A and E7 proteins to target cells
for rejection by the host natural killer (NK) cell response. As one test of
this hypothesis, we compared the abilities of E1A- and E7- expressing human
fibroblastic or keratinocyte-derived human cells to be selectively killed
by either unstimulated or interferon (IFN)-activated NK cells. Cells
expressing the E1A oncoprotein were selectively killed by unstimulated NK
cells, while the same parental cells but expressing the HPV type 16
(HPV-16) or HPV-18 E7 oncoprotein were resistant to NK cell lysis. The
ability of IFN-activated NK cells to selectively kill virally transformed
cells depends on IFN's ability to induce resistance to NK cell lysis in
normal (i.e., non-viral oncogene-expressing) but not virally transformed
cells. E1A blocked IFN's induction of cytolytic resistance, resulting in
the selective lysis of adenovirus-transformed cells by IFN-activated NK
cells. The extent of IFN-induced NK cell killing of E1A-expressing cells
was proportional to the level of E1A expression and correlated with the
ability of E1A to block IFN- stimulated gene expression in target cells. In
contrast, E7 blocked neither IFN-stimulated gene expression nor IFN's
induction of cytolytic resistance, thereby precluding the selective lysis
of HPV-transformed cells by IFN-activated NK cells. In conclusion, E1A
expression marks cells for destruction by the host NK cell response,
whereas the E7 oncoprotein lacks this activity.
Copyright © 1995, American Society for Microbiology
Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells
Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, USA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|